AI Science Tracker

A machine-learning plasma panel classifies some REM sleep behavior disorder participants years before motor Parkinson diagnosis

University of Oxford; University Medical Center Göttingen and collaborating European research institutions · 18 Jun 2024 · medicine

Discovery

A machine-learning plasma panel classifies some REM sleep behavior disorder participants years before motor Parkinson diagnosis

Researchers developed a targeted multiplex mass-spectrometry assay for eight plasma proteins and applied machine learning to distinguish Parkinson disease from healthy controls and classify people with isolated REM sleep behavior disorder (iRBD). In the reported longitudinal iRBD cohorts, the model classified 79% of participants up to seven years before motor Parkinson disease or dementia with Lewy bodies onset. The work connects a targeted protein panel to a pre-motor disease signal in measured blood samples.

Technology: Machine-learning classifier using recursive feature elimination on targeted plasma proteomic measurements

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Researchers developed a targeted multiplex mass-spectrometry assay for eight plasma proteins and applied machine learning to distinguish Parkinson disease from healthy controls and classify people with isolated REM sleep behavior disorder (iRBD).
  • Still unknown: The discovery phase used only 10 Parkinson cases and 10 controls. Although the study includes larger targeted-assay cohorts, the longitudinal iRBD groups were small (18 and 54 participants), and the finding is not a validated screening test or proof that intervention changes outcomes. The model’s apparent early classification needs larger prospective cohorts.
  • AI role: The classifier selected an eight-protein panel from targeted mass-spectrometry measurements, then classified motor Parkinson cases and iRBD participants; the longitudinal analysis linked panel scores with later clinical conversion.

Evidence sources: https://www.nature.com/articles/s41467-024-48961-3

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 139 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.